IE
VCYT icon

Israel Englander’s Veracyte VCYT Stock Holding History

Israel Englander’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$275K – 6690
2023
Q4 		$275K Buy
+10,000
New +$241K ﹤0.01% 5004
2022
Q1 		– Sell
-5,000
Closed -$206K – 7524
2021
Q4 		$206K Buy
+5,000
New +$221K ﹤0.01% 5887

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Israel Englander's VCYT Position: Q2 2026 in Review

Israel Englander opened a new position in Veracyte (VCYT) in Q2 2026: 71,982 shares worth $4.23M. The stake represents ﹤0.01% of the portfolio and ranks #3146 among its holdings. This is a return to the name: Israel Englander previously reported a position in VCYT as recently as Q4 2025.

Israel Englander first reported a position in VCYT in Q4 2013 and has held it in 46 quarters since. The position peaked at $20.5M in Q1 2019. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Israel Englander held 71,982 shares of Veracyte worth $4.23M as of Q2 2026.
  • Veracyte was a new Israel Englander position in Q2 2026.
  • Veracyte made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3146 holding.
  • Israel Englander first reported a position in Veracyte in Q4 2013 and has held it in 46 quarters since.
  • Israel Englander's Veracyte position peaked at $20.5M in Q1 2019.
  • 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.